Literature Review of PBT for Prostate Cancer in Japan.
01/01/2019
/
Publications
A literature review on published works related to proton beam therapy for prostate cancer in Japan. 23 articles were analyzed including fourteen observational...
LT results of a phase II study of hypofractionated PT for prostate cancer
01/01/2019
/
Publications
A study by the Korean group of National Cancer Center. Eighty-two patients with T1-3bN0M0 prostate cancer were randomized to one of five arms: Arm 1, 60 cobalt...
Analysis of Gastrointestinal Toxicity in Patients Receiving PBT for Prostate Cancer
08/08/2018
/
Publications
/
Toxicity
A study by the Seattle group. 192 prostate cancer patients were treated with PBT. With the median follow-up of 1.7 years, most of the observed GI toxicity (>90%...
Comparison of Grade 4 Lymphopenia With PT Vs Photon Therapy for Esophageal Cancer.
01/01/2019
/
Publications
/
Survival
Grade 4 lymphopenia (G4L) during radiation therapy (RT) is associated with higher rates of distant metastasis and decreased overall survival. 79 patients...
Proton Therapy for Prostate Cancer
11/09/2018
/
Publications
/
Dosimetry
Clinical Trial
A review examined the dosimetric rationale and theoretical benefit of proton radiation for prostate cancer and the current state of the clinical evidence for...
Effectiveness of Particle Radiotherapy in Various Stages of HCC
11/03/2018
/
Publications
/
Survival
A retrospective report from Japan. Eighty-three patients with HCC underwent particle therapy including proton beam radiation in 58 patients and carbon ion...
Proton beam therapy for gastrointestinal cancers
11/10/2018
/
Publications
A review on recent data that PBT for upper GI cancers may decrease acute toxicity and late complications and improve treatment compliance.
The authors examined...
Current and emerging radiotherapy strategies for pancreatic adenocarcinoma.
08/08/2018
/
Publications
/
IMRT
A review article by MD Anderson examined the available outcome data of IMRT, SBRT and proton and carbon ion therapy for locally advanced pancreatic cancer, and...
Initial experience with IMPT for intact, clinically localized pancreas cancer.
08/04/2018
/
Publications
/
IMPT
Chemotherapy
A Mayo Clinic study reported outcomes of IMPT for intact and clinically localized pancreatic cancer. 13 patients with localized pancreatic cancer underwent...
Initial toxicity, QoL outcomes, and dosimetric impact in a randomized phase 3 trial of hypofractionated vs. standard fractionated PT for low-risk prostate cancer
08/02/2018
/
Publications
/
Hypofractionation
Quality of life
A multi-center prospective phase 3 randomized trial aimed to identify differences in toxicity and quality-of-life outcomes between standard fractionation and...
Cookies policy
If you continue browsing this website, you agree to the use of cookies in order to provide you with services and offers tailored to your own interests.
Manage your cookie preferences
Respect for your privacy is still a priority for us at IBA.
Functional cookies ensure that the website runs smoothly. They cannot be turned off. By setting your preferences, you can turn the use of these cookies on and off on our website, although these settings will only be valid on the device you are currently using.